Janssen to Pay $14.5 Million to Resolve Pending Propulsid Cases



DOCUMENTS
  • Dec. 19, 2005 Consent Order
  • Feb. 4, 2004 Consent Order
  • Term Sheet


NEW ORLEANS -Janssen Pharmaceutica will pay at least $14.5 million to resolve all remaining state and federal lawsuits in the second MDL resolution program related to its Propulsid (cisapride) heartburn medication. In Re: Propulsid Products Liability Litigation. MDL No. 1355. Case No. 2:00-md-01355 (E.D. La.).

Judge Eldon E. Fallon of the U.S. District Court for the Eastern District of Louisiana issued a consent order on Dec. 19.

Janssen Pharmaceutica, a Johnson & Johnson company, will pay a minimum of $14.5 million and a maximum of $15 million in compensation, J&J said. Janssen will also establish a maximum of $3 million …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024 - Salt Lake City, UT
The Grand America Hotel

MORE DETAILS



HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo

MORE DETAILS